The Centers for Disease Control and Prevention today urged state and local health departments and health care facilities to work with its Antibiotic Resistance Lab Network to implement a coordinated strategy to prevent the spread of unusual germs that are resistant to all or most antibiotics or can spread their resistance to other germs, reporting more than 220 instances of such germs in the United States last year. The strategy calls for rapid identification of resistance, infection control assessments, testing patients who are without symptoms but possibly carrying and spreading the germ, and continued infection control assessments until spread is stopped. “CDC’s study found several dangerous pathogens, hiding in plain sight, that can cause infections that are difficult or impossible to treat,” said CDC Principal Deputy Director Anne Schuchat, M.D. “It’s reassuring to see that state and local experts, using our containment strategy, identified and stopped these resistant bacteria before they had the opportunity to spread.” For more on the CDC study and strategy, visit https://www.cdc.gov/vitalsigns/containing-unusual-resistance. CDC also will host an April 10 Town Hall Teleconference (https://www.cdc.gov/stltpublichealth/townhall/2018/4-apr.html) on how states are implementing the strategy. For additional tools to prevent antibiotic resistance, including an antimicrobial stewardship toolkit, visit http://www.ahaphysicianforum.org/resources/appropriate-use/antimicrobial.    

Related News Articles

Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia.
Headline
The number of U.S. hospitals with an antibiotic stewardship program that meets all core elements recommended by the Centers for Disease Control and Prevention…
Headline
In a commentary published in Academic Medicine, experts outline how academic medicine, medical education, public health agencies, hospital associations and…
Headline
HHS and the Department of Defense’s Defense Threat Reduction Agency will provide funding to VenatoRx Pharmaceuticals to develop a novel antibiotic to treat…
Headline
Public or non-profit community-based organizations may apply for funding to support innovative research proposals to prevent health care-associated infections…
Headline
An estimated 23 percent of outpatient antibiotic prescriptions filled by privately insured children and non-elderly adults in the United States in 2016 were…